NOVARTIS To Charge $475,000 For $20,000 Cancer Cure Funded By Taxpayers And Charity

Crap like this really makes you think twice about donating to Charity organizations that fund research as the damned Pharmaceutical companies will
just end up taking it and robbing the public anyway. This story is about a leukemia cure that was funded by taxpayer and charity money because the
Pharmaceutical companies wouldn't (you know, cures are not what they are in business for).

So, after the cure has went through trials (and cost less than 20K not even under mass-production which should actually reduce the cost) these SOB's
get their hands on the distribution rights and want to charge almost $500K .......

A virtual cure for leukemia - paid for by taxpayers and charity, hijacked and sold for nearly half a million dollars by pharmaceutical giant,
Novartis. www.technologyreview.com...

For the past 20 years, American taxpayers through the National Institutes of Health (NIH) and the Leukemia & Lymphoma Society (LLS) helped fund a
revolutionary cancer treatment that sidesteps devastating and ineffective chemotherapy and instead, re-engineers a patient's own immune system to
find and destroy tumors.

In most articles, concerted attempts are made to portray the $475,000 price tag as more reasonable than previous "expert" estimates. One article
published by STAT even claimed the nearly half million price tag was a "bargain."

Novartis clearly did not develop this breakthrough. It merely bought the license to commercialize and market it to the public.

In reality, the cost of curing Emily Whitehead in 2012 under highly experimental conditions, using customized equipment cost under $20,000. The head
researcher, University of Pennsylvania's Dr. Carl June, has repeatedly stated in public that while the cost was under $20,000 when he and his team
provided the therapy, upon commercialization, with automation it should cost even less.

We received a lot of money over the last 15 years from the Leukemia [& Lymphoma] Society and they've been the primary ones that developed this. There
was no industry support available.

And applications have been made so it can be used in Europe and the UK. That means, if someone in the UK needs it, they will get it under the "awful
socialist" (as some put it) NHS for no more than what they're currently paying (TAX).

Also, for the US residents, from your first link it says....

The one-time treatment will cost $475,000, but Novartis says there will be no charge if a patient doesn't respond to the therapy within a
month.

And people in the US wonder why people outside of the US are laughing at your healthcare service.

a reply to: infolurker
Edit: This is no free market, at some point this will all be corrected. But for the time being the people in control are stripping every last dollar
they can before the correction in medical.
Our system is a force monopoly with no consumer protection.

The cost of these treatments (that are needed) are what is driving the cost of medical out of sight. Not the $100 visit to the Dr.

We need medical reform, and single payer seems to control costs much better than our form of capitalism.

That can be fixed in a few quick steps... Also, Single Payer will not work unless these other issues are addressed. We will just have the highest cost
single payer in the world and the same jackasses will be even richer. Informative Research Below:

This content community relies on user-generated content from our member contributors. The opinions of our members are not those of site ownership who maintains strict editorial agnosticism and simply provides a collaborative venue for free expression.